ASLAN Pharmaceuticals, a biotech company focused on the development of immunotherapies and targeted agents for Asia-prevalent tumour types, will move to a new office in Taiwan with immediate effect.
The new location will allow ASLAN to support its growing business in Taiwan and the Asia region, further strengthening the company’s capabilities and local presence.
The Taiwan office is one of three regional offices in Asia Pacific that drives ASLAN’s clinical development strategy in the region. ASLAN has operational presence in Singapore, China and Australia.
The address of the new office is:
ASLAN Pharmaceuticals Taiwan, 35F, 68 Zhongxiao East Road Section 5, Xinyi District, Taipei 110, Taiwan.
